418 related articles for article (PubMed ID: 15113085)
1. Peptide and amino acid glycation: new insights into the Maillard reaction.
Horvat S; Jakas A
J Pept Sci; 2004 Mar; 10(3):119-37. PubMed ID: 15113085
[TBL] [Abstract][Full Text] [Related]
2. Study of degradation pathways of Amadori compounds obtained by glycation of opioid pentapeptide and related smaller fragments: stability, reactions, and spectroscopic properties.
Jakas A; Horvat S
Biopolymers; 2003 Aug; 69(4):421-31. PubMed ID: 12879488
[TBL] [Abstract][Full Text] [Related]
3. Site-specific synthesis of Amadori-modified peptides on solid phase.
Frolov A; Singer D; Hoffmann R
J Pept Sci; 2006 Jun; 12(6):389-95. PubMed ID: 16342332
[TBL] [Abstract][Full Text] [Related]
4. Maillard reaction products in tissue proteins: new products and new perspectives.
Thorpe SR; Baynes JW
Amino Acids; 2003 Dec; 25(3-4):275-81. PubMed ID: 14661090
[TBL] [Abstract][Full Text] [Related]
5. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
[TBL] [Abstract][Full Text] [Related]
6. The Maillard reaction induced modifications of endogenous opioid peptide enkephalin.
Jakas A
Methods Mol Biol; 2013; 1081():137-49. PubMed ID: 24014438
[TBL] [Abstract][Full Text] [Related]
7. Transformations of bioactive peptides in the presence of sugars--characterization and stability studies of the adducts generated via the Maillard reaction.
Roscić M; Horvat S
Bioorg Med Chem; 2006 Jul; 14(14):4933-43. PubMed ID: 16563774
[TBL] [Abstract][Full Text] [Related]
8. Formation of reactive intermediates from Amadori compounds under physiological conditions.
Zyzak DV; Richardson JM; Thorpe SR; Baynes JW
Arch Biochem Biophys; 1995 Jan; 316(1):547-54. PubMed ID: 7840665
[TBL] [Abstract][Full Text] [Related]
9. The Maillard reaction and its consequences for a living body.
Sztanke K; Pasternak K
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
[TBL] [Abstract][Full Text] [Related]
10. Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods.
Henle T
Amino Acids; 2005 Dec; 29(4):313-22. PubMed ID: 15997413
[TBL] [Abstract][Full Text] [Related]
11. The effect of glycation on the chemical and enzymatic stability of the endogenous opioid peptide, leucine-enkephalin, and related fragments.
Jakas A; Horvat S
Bioorg Chem; 2004 Dec; 32(6):516-26. PubMed ID: 15530992
[TBL] [Abstract][Full Text] [Related]
12. The early glycation products of the Maillard reaction: mass spectrometric characterization of novel imidazolidinones derived from an opioid pentapeptide and glucose.
Roscić M; Versluis C; Kleinnijenhuis AJ; Horvat S; Heck AJ
Rapid Commun Mass Spectrom; 2001; 15(12):1022-9. PubMed ID: 11400213
[TBL] [Abstract][Full Text] [Related]
13. Protein glycation: creation of catalytic sites for free radical generation.
Yim MB; Yim HS; Lee C; Kang SO; Chock PB
Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
[TBL] [Abstract][Full Text] [Related]
14. The Amadori product on protein: structure and reactions.
Baynes JW; Watkins NG; Fisher CI; Hull CJ; Patrick JS; Ahmed MU; Dunn JA; Thorpe SR
Prog Clin Biol Res; 1989; 304():43-67. PubMed ID: 2675036
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products/peptides: an in vivo investigation.
Lapolla A; Fedele D; Reitano R; Bonfante L; Pastori G; Seraglia R; Tubaro M; Traldi P
Ann N Y Acad Sci; 2005 Jun; 1043():267-75. PubMed ID: 16037247
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
Szwergold BS
Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end-products prepared in solution under high pressure contain epitopes distinct from those formed in the dry reaction at high temperature.
Staniszewska M; Jarosz J; Jon M; Gamian A
Arch Immunol Ther Exp (Warsz); 2005; 53(1):71-8. PubMed ID: 15761378
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of amadoriase I from Aspergillus fumigatus.
Mennella C; Borrelli RC; Vinale F; Ruocco M; Fogliano V
Ann N Y Acad Sci; 2005 Jun; 1043():837-44. PubMed ID: 16037311
[TBL] [Abstract][Full Text] [Related]
19. GC-MS Method for the Quantitation of Carbohydrate Intermediates in Glycation Systems.
Milkovska-Stamenova S; Schmidt R; Frolov A; Birkemeyer C
J Agric Food Chem; 2015 Jul; 63(25):5911-9. PubMed ID: 26043919
[TBL] [Abstract][Full Text] [Related]
20. Contribution of mass spectrometry to the study of the Maillard reaction in food.
Fay LB; Brevard H
Mass Spectrom Rev; 2005; 24(4):487-507. PubMed ID: 15389846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
